Cahill Gordon & Reindel LLP
08/21/2025 | Press release | Archived content
Firm News: Cahill Represents Lead Arrangers in QuidelOrtho’s $3.4 Billion Credit Facility 08.21.2025
Cahill Represents Lead Arrangers in QuidelOrtho's $3.4 Billion Credit Facility
Date: 08/21/25
Cahill represented the lead arrangers in connection with a $1.15 billion Term A credit facility, a $100 million delayed draw Term A facility, a $1.45 billion Term B credit facility, and a $700 million revolving credit facility for QuidelOrtho Corporation.
Proceeds from the credit facility will be used for general corporate purposes and a refinancing existing credit.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products.
Cahill Gordon & Reindel LLP published this content on August 21, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 16, 2025 at 19:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]